US 11338029
Cancer vaccines targeting PRAME and uses thereof
granted A61KA61K2039/53A61K2039/55527
Quick answer
US patent 11338029 (Cancer vaccines targeting PRAME and uses thereof) held by Inovio Pharmaceuticals, Inc. expires Mon May 19 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Inovio Pharmaceuticals, Inc.
- Grant date
- Tue May 24 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 19 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K2039/53, A61K2039/55527, A61K2039/55533, A61K2039/55538